An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer
Clinical trial NCT00537381 · COMPLETED
Trial details
- NCT number
- NCT00537381
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-11-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.